| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anemia profiles in patients with lung cancer: What have we learned from the European Cancer Anaemia Survey (ECAS)?
|
Kosmidis, Paris
|
|
2005
|
50 |
3 |
p. 401-412
12 p.
|
artikel
|
| 2 |
Calendar of Events
|
|
|
2005
|
50 |
3 |
p. ix-
1 p.
|
artikel
|
| 3 |
Contents
|
|
|
2005
|
50 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 4 |
Corrigendum to “Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience” [Lung Cancer 49S1 (2005) S83–S86]
|
Münter, Marc W.
|
|
2005
|
50 |
3 |
p. 423-
1 p.
|
artikel
|
| 5 |
Corrigendum to “Treatment planning system evaluation for mesothelioma IMRT” [Lung Cancer 49S1 (2005) S75–S81]
|
Stevens, Craig W.
|
|
2005
|
50 |
3 |
p. 425-
1 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2005
|
50 |
3 |
p. iii-
1 p.
|
artikel
|
| 7 |
Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer
|
Yasufuku, Kazuhiro
|
|
2005
|
50 |
3 |
p. 347-354
8 p.
|
artikel
|
| 8 |
Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay
|
Endo, Katsuhiko
|
|
2005
|
50 |
3 |
p. 375-384
10 p.
|
artikel
|
| 9 |
Erratum to “Abstracts of the 11th World Conference on Lung Cancer, 3–6 July, Barcelona, Spain” [Lung Cancer 49S2 (2005) S148]
|
|
|
2005
|
50 |
3 |
p. 427-
1 p.
|
artikel
|
| 10 |
Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study
|
Hotta, Katsuyuki
|
|
2005
|
50 |
3 |
p. 413-415
3 p.
|
artikel
|
| 11 |
Interleukin-8 in non-small cell lung carcinoma: Relation with angiogenic pattern and p53 alterations
|
Boldrini, Laura
|
|
2005
|
50 |
3 |
p. 309-317
9 p.
|
artikel
|
| 12 |
Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: A possible interaction with polymorphisms in the interleukin 1 beta gene
|
Lind, Helge
|
|
2005
|
50 |
3 |
p. 285-290
6 p.
|
artikel
|
| 13 |
Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
|
Camps, Carlos
|
|
2005
|
50 |
3 |
p. 339-346
8 p.
|
artikel
|
| 14 |
Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer
|
Viswanathan, Avinash
|
|
2005
|
50 |
3 |
p. 417-418
2 p.
|
artikel
|
| 15 |
Lung cancer in patients with chronic lymphocytic leukemia
|
Musolino, Antonino
|
|
2005
|
50 |
3 |
p. 419-420
2 p.
|
artikel
|
| 16 |
Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery
|
Kondo, Masashi
|
|
2005
|
50 |
3 |
p. 385-391
7 p.
|
artikel
|
| 17 |
Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma
|
Kouidou, Sofia
|
|
2005
|
50 |
3 |
p. 299-307
9 p.
|
artikel
|
| 18 |
Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib
|
Kimura, Hideharu
|
|
2005
|
50 |
3 |
p. 393-399
7 p.
|
artikel
|
| 19 |
Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin
|
Poulsen, Thomas T.
|
|
2005
|
50 |
3 |
p. 329-337
9 p.
|
artikel
|
| 20 |
Targeting small-cell lung cancer with novel fluorescent analogs of somatostatin
|
Kostenich, Genady
|
|
2005
|
50 |
3 |
p. 319-328
10 p.
|
artikel
|
| 21 |
Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline
|
Chu, Quincy
|
|
2005
|
50 |
3 |
p. 355-374
20 p.
|
artikel
|
| 22 |
The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer
|
Shih, Chuen-Ming
|
|
2005
|
50 |
3 |
p. 291-297
7 p.
|
artikel
|
| 23 |
The 4th IASLC Chinese International Conference on Lung Cancer
|
|
|
2005
|
50 |
3 |
p. 421-422
2 p.
|
artikel
|
Tijdschrift beschrijving